Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Ming-Zhu Xu"'
Autor:
Yan-Yan Li, Shuai-Shuai Ge, Yuan-Hong Huang, Ming-Zhu Xu, Chao-Ling Wan, Kai-Wen Tan, Tao Tao, Hai-Xia Zhou, Sheng-Li Xue, Hai-Ping Dai
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-5 (2024)
Externí odkaz:
https://doaj.org/article/28a5249897d5441e98a9d67e6f83e339
Autor:
Si‐Man Huang, Chao‐Ling Wan, Han‐Yu Cao, Yan‐Yan Li, Chong‐Sheng Qian, Hai‐Xia Zhou, Ming‐Zhu Xu, Xiao‐Hui Hu, Lan Dai, Hai‐Ping Dai, Sheng‐Li Xue
Publikováno v:
Clinical Case Reports, Vol 11, Iss 12, Pp n/a-n/a (2023)
Key Clinical Message There are no reports of application of inotuzumab ozogamicin (InO) for the treatment of MRD in r/r B‐ALL. We firstly report the efficacy of InO for a patient experienced morphological relapse after HSCT and molecular relapse af
Externí odkaz:
https://doaj.org/article/e00f4ab4696542c7889d7aed2a24ad24
Autor:
Jing-Ying Zou, Si-Man Huang, Hai-Xia Zhoub, Ming-Zhu Xu, Ai-Ning Sun, De-Pei Wu, Sheng-Li Xue, Tong-Tong Zhang
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTObjectives: Venetoclax has shown synergism with BCR-ABL1 tyrosine kinase inhibitors (TKIs) in preclinical studies for patients with Philadelphia chromosome-positive (Ph+) leukemias. This combination may suggest a novel treatment strategy for
Externí odkaz:
https://doaj.org/article/f1cfee49a2964707ab25a52fd8865ca5
Autor:
Yan Qiu, Chao-Ling Wan, Ming-Zhu Xu, Hai-Xia Zhou, Mei-Jing Liu, Wen-Jie Gong, Li-Qing Kang, Ai-Ning Sun, Lei Yu, De-Pei Wu, Chong-Sheng Qian, Sheng-Li Xue
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/5ac399e240104f459bc6058032c3c523
Autor:
Jia Yin, Chao-Ling Wan, Ling Zhang, Hao Zhang, Lian Bai, Hai-Xia Zhou, Ming-Zhu Xu, Li-Yun Chen, Chong-Sheng Qian, Hui-Ying Qiu, Su-Ning Chen, Xiao-Wen Tang, De-Pei Wu, Yan-Ming Zhang, Ai-Ning Sun, Sheng-Li Xue
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
ObjectiveTo explore the role of chidamide, decitabine plus priming regimen in the salvage treatment of relapsed/refractory acute myeloid leukemia.MethodsA clinical trial was conducted in relapsed/refractory acute myeloid leukemia patients using chida
Externí odkaz:
https://doaj.org/article/ebb3a1cfd5874ae09a8857c3577bbddd
Autor:
Liyun Chen, Wen-Jie Gong, Ming-Hao Li, Hai-Xia Zhou, Ming-Zhu Xu, Chong-Sheng Qian, Li-Qing Kang, Nan Xu, Zhou Yu, Man Qiao, Tong-Tong Zhang, Ling Zhang, Zheng-Long Tian, Ai-Ning Sun, Lei Yu, De-Pei Wu, Sheng-Li Xue
Publikováno v:
Blood Advances.
We conducted a single-arm, open-label, single-center phase I study (Clinicaltrials.gov NCT03984968) to assess the safety and efficacy of multicycle-sequential anti-CD19 CAR T-cell therapy in combination with autologous CD19+ feeding T cells (FTCs) an
Autor:
Lei-Si Zhang, Jun Wang, Ming-Zhu Xu, Tian-Mei Wu, Si-Man Huang, Han-Yu Cao, Ai-Ning Sun, Song-Bai Liu, Sheng-Li Xue
Publikováno v:
OncoTargets and Therapy. 15:159-164
Lei-Si Zhang,1,2,* Jun Wang,1,2,* Ming-Zhu Xu,1,2,* Tian-Mei Wu,1,2 Si-Man Huang,1,2 Han-Yu Cao,1,2 Ai-Ning Sun,1,2 Song-Bai Liu,3 Sheng-Li Xue1,2 1National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematolog
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 30(6)
To compare the clinical efficacy and safety of hypomenthylating agents (HMA) combined with Venetoclax (VEN) and half dose priming regimen (CAG-like) in the treatment of elderly patients with newly diagnosed acute myeloid leukemia (AML) who were not s
Autor:
Yan Qiu, Chong-Sheng Qian, Hai-Xia Zhou, Ming-Zhu Xu, Li-Qing Kang, Ai-Ning Sun, De-Pei Wu, Lei Yu, Shengli Xue
Publikováno v:
Blood. 140:10337-10338
Autor:
Kang-Kang, Lyu, Mi-Mi, Xu, Yuan-Yuan, DU, Xue-Feng, He, Feng, Chen, Xiao, Ma, Yue, Han, De-Pei, Wu, Yue-Jun, Liu, Ming-Zhu, Xu
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 30(2)
Objective: To investigate the role and mechanism of circulating follicular helper T cells (cTfh), extrafollicular helper T cells, B cells and their subsets in chronic graft-versus-host disease (cGVHD) after transplantation.Peripheral blood of cGVHD 6